Navigation Links
Ultrasound With Elastography May Cut Down on Biopsies
Date:12/1/2009

Method improves diagnosis of benign versus cancerous lesions, researchers say

TUESDAY, Dec. 1 (HealthDay News) -- When used with ultrasound, elastography helps distinguish between cancerous and benign breast lesions, which reduces unnecessary biopsies, U.S. researchers have found.

About 80 percent of breast lesions that are biopsied turn out to be benign, according to the American Cancer Society.

"There's a lot of room to improve specificity with ultrasound, and elastography can help us do that," Dr. Stamatia V. Destounis, a diagnostic radiologist at Elizabeth Wende Breast Care in Rochester, N.Y., and the study's lead author, said in a news release from the Radiological Society of North America. "It's an easy way to eliminate needle biopsy for something that's probably benign."

Elastography measures the compressibility and mechanical properties of a lesion. Cancerous tumors tend to be stiffer than surrounding tissues or cysts, whereas benign lesions are more compressible.

"You can perform elastography at the same time as hand-held ultrasound and view the images on a split screen, with the two-dimensional ultrasound image on the left and the elastography image on the right," Destounis said.

As part of an ongoing study, 179 women underwent breast ultrasound and elastography. The researchers performed biopsies on the 134 solid lesions they detected. . They found that elastography correctly identified 98 percent of cancerous lesions and 82 percent of benign lesions, and they also determined that elastography was more accurate than ultrasound in gauging the size of the lesions.

The findings were to be presented Nov. 30 in Chicago at the annual meeting of the Radiological Society of North America.

In another study scheduled to be presented at the meeting, researchers found that high-frequency ultrasound with elastography can help distinguish between cancerous and benign skin lesions, which could improve the efficiency of skin cancer diagnosis.

Dr. Eliot L. Siegel, vice chairman of the radiology department at the University of Maryland School of Medicine in Baltimore and the study's lead author, said in the news release that "dermatologists tend to biopsy any lesions that seem visually suspicious for disease."

"Consequently," he said, "many benign lesions are needlessly biopsied in order to avoid the risk of missing a potentially deadly melanoma."

Siegel and his colleagues used ultra-high-frequency ultrasound to image cancerous and benign skin lesions on 40 people. They also calculated the elasticity ratio of the lesions and adjacent normal skin and used laboratory analysis to confirm their diagnoses. They found that benign lesions had high levels of elasticity, whereas cancerous lesions were much less elastic. The elasticity ratio of normal skin to adjacent lesions ranged from 0.04 to 0.3 for benign lesions to above 10.0 for cancerous lesions.

"The visualized portion of a skin lesion can be just the tip of the iceberg, and most dermatologists operate 'blindly' beyond what they can see on the surface," Siegel said. "High-frequency ultrasound provides almost microscopic resolution and enables us to get size, shape and extent of the lesion prior to biopsy."

More information

The U.S. National Cancer Institute has more about cancer diagnosis.



-- Robert Preidt



SOURCE: Radiological Society of North America, news release, Dec. 1, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Special ultrasound accurately identifies skin cancer
2. Special Ultrasound Accurately Identifies Skin Cancer
3. Simulated training for ultrasound-guided procedures improves safety without risk to patients
4. Philips Healthcare CEO Joins Focused Ultrasound Surgery Foundation Board of Directors
5. Dr. Marc Katz, Leading Podiatric Surgeon Adds High Powered Color Ultrasound To Cryosurgery Procedures and Treatments
6. Ultrasound can predict tumor burden and survival in melanoma patients
7. MEDISON Launches New Dedicated OB/GYN 3D/4D Ultrasound System, ACCUVIX V20 Prestige
8. Mindray DS USA Appoints Michael Thompson Vice President of U.S. Ultrasound Sales
9. ALOKA Announces New ProSound Alpha Series Ultrasound System
10. Tennis Elbow, Shin Splints and Carpal Tunnel Syndrome Could Be a Thing of the Past Due to New Efforts with Sports Musculoskeletal Ultrasound
11. AIUM announces management agreement with the International Society of Therapeutic Ultrasound
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2017)... (PRWEB) , ... April 29, 2017 , ... ... celebrate the profession and recognize the positive impact veterinarians have on animal health ... and the World Organization for Animal Health (OIE) choose a theme each year ...
(Date:4/28/2017)... NC (PRWEB) , ... April 28, 2017 , ... ... announce its new partnership with the Home Care Association of America (HCAOA). This ... and Private Duty Accreditation services, as well as discounts on Accreditation University (AU) ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... Beginning in ... of their formulas. This begins with the popular ClearLungs Extra Strength formula. To ensure ... changing the formula in the following ways:, , Removal of ...
(Date:4/28/2017)... ... April 28, 2017 , ... ... distribution of the GlycoMark test throughout the Northeast U.S. , GlycoMark is ... with diabetes. The GlycoMark test provides a clinically proven one- to two-week measure ...
(Date:4/28/2017)... Fairfax, VA (PRWEB) , ... April 28, 2017 , ... ... elected volunteer board members and officers for 2017-2018. The annual board election process has ... serving on a volunteer basis. , Thomas C. Dickerson, Ed.D., FACHE, succeeds Jim Hamilton, ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... MINNEAPOLIS , April 20, 2017  Cogentix ... company focused on providing the Urology, Uro/Gyn and ... reported that Ash Keswani has joined the Company ... In this newly created position, Mr. Keswani will ... and CEO. "Our organization is delighted ...
(Date:4/20/2017)... Research and Markets has announced the addition of the ... Market and Increasing Usage of Complex Biologics during the Forecast Period" ... ... 20 Billion in 2015 to around USD 26 Billion by 2020. ... by Rapidly Expanding Injectables Market and Increasing Usage of Complex Biologics ...
(Date:4/20/2017)... 20, 2017 Eyevensys, a private ... non-viral gene expression technology that enables the safe, local, ... address a wide range of ophthalmic diseases, announces it ... products Regulatory Agency (MHRA) to advance its technology into ... ...
Breaking Medicine Technology: